He says the woman's retatrutide came from neither Lilly nor a compounding pharmacy, and her liver failed within six days of starting it.
Recap by typeshit. Post by @drzainhasan on Instagram.
He describes a case where a product sourced from neither Eli Lilly nor a compounding pharmacy was followed by liver failure within six days.
The pharmacists' group says the drug looks promising but urges patients to understand what they risk with unofficial sources, and points to its SafeMedication site.
The pharmacists' group points people to its SafeMedication site for a patient-friendly explainer on retatrutide and why unofficial sources are risky.
22:55
Dr. Aleksandra Brown breaks down the buzz around copper peptides and how topical serums compare with injected GHK-Cu.
6:25
Dr Almerie compares Lilly's experimental retatrutide with Mounjaro and talks through the case for switching versus holding off until it's approved.
She explains that GLP-1 drugs copy a hormone the body already makes, and says they can curb appetite, slow digestion and help with blood sugar.
Loading…